Literature DB >> 19207078

High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy.

Serena P Koenig1, Cynthia Riviere, Paul Leger, Patrice Joseph, Patrice Severe, Kea Parker, Sean Collins, Erin Lee, Jean W Pape, Daniel W Fitzgerald.   

Abstract

We analyzed mortality among 201 patients with AIDS and tuberculosis in Haiti. Patients who received a diagnosis of tuberculosis during the first 3 months after the initiation of antiretroviral therapy were 3.25 times more likely to die than were other patients with AIDS and tuberculosis. Failure to recognize active tuberculosis at initiation of antiretroviral therapy leads to increased mortality.

Entities:  

Mesh：

Year:  2009        PMID： 19207078      PMCID： PMC3010922          DOI： 10.1086/597098

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  11 in total

1.  Treatment of tuberculosis.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2003-06-20

2.  Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial.

Authors:  D W Fitzgerald; M Desvarieux; P Severe; P Joseph; W D Johnson; J W Pape
Journal:  Lancet       Date:  2000-10-28       Impact factor: 79.321

3.  Antiretroviral therapy in a thousand patients with AIDS in Haiti.

Authors:  Patrice Severe; Paul Leger; Macarthur Charles; Francine Noel; Gerry Bonhomme; Gyrlande Bois; Erik George; Stefan Kenel-Pierre; Peter F Wright; Roy Gulick; Warren D Johnson; Jean William Pape; Daniel W Fitzgerald
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

4.  Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.

Authors:  Stephen D Lawn; Landon Myer; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2006-08-01       Impact factor: 4.177

5.  Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy.

Authors:  Ronan A M Breen; R F Miller; T Gorsuch; C J Smith; J Ainsworth; J Ballinger; L Swaden; I Cropley; M A Johnson; M C I Lipman
Journal:  J Infect Dis       Date:  2006-04-04       Impact factor: 5.226

Review 6.  Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes.

Authors:  Haileyesus Getahun; Mark Harrington; Rick O'Brien; Paul Nunn
Journal:  Lancet       Date:  2007-06-16       Impact factor: 79.321

7.  Outcomes of tuberculosis patients who start antiretroviral therapy under routine programme conditions in Malawi.

Authors:  S D Makombe; A D Harries; J K-L Yu; M Hochgesang; E Mhango; R Weigel; O Pasulani; M Fitzgerald; E J Schouten; E Libamba
Journal:  Int J Tuberc Lung Dis       Date:  2007-04       Impact factor: 2.373

8.  Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.

Authors:  David Moore; Cheryl Liechty; Paul Ekwaru; Willy Were; Gerald Mwima; Peter Solberg; George Rutherford; Jonathan Mermin
Journal:  AIDS       Date:  2007-03-30       Impact factor: 4.177

9.  Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings.

Authors:  Graeme Meintjes; Stephen D Lawn; Fabio Scano; Gary Maartens; Martyn A French; William Worodria; Julian H Elliott; David Murdoch; Robert J Wilkinson; Catherine Seyler; Laurence John; Maarten Schim van der Loeff; Peter Reiss; Lut Lynen; Edward N Janoff; Charles Gilks; Robert Colebunders
Journal:  Lancet Infect Dis       Date:  2008-08       Impact factor: 25.071

10.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

Authors:  Paula Braitstein; Martin W G Brinkhof; François Dabis; Mauro Schechter; Andrew Boulle; Paolo Miotti; Robin Wood; Christian Laurent; Eduardo Sprinz; Catherine Seyler; David R Bangsberg; Eric Balestre; Jonathan A C Sterne; Margaret May; Matthias Egger
Journal:  Lancet       Date:  2006-03-11       Impact factor: 79.321
View more
  31 in total

1.  Successes and challenges of HIV treatment programs in Haiti: aftermath of the earthquake.

Authors:  S Koenig; Lc Ivers; S Pace; R Destine; F Leandre; R Grandpierre; J Mukherjee; Pe Farmer; Jw Pape
Journal:  HIV Ther       Date:  2010-03

2.  Clinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting.

Authors:  Serena P Koenig; Bruce R Schackman; Cynthia Riviere; Paul Leger; Macarthur Charles; Patrice Severe; Charlene Lastimoso; Nicole Colucci; Jean W Pape; Daniel W Fitzgerald
Journal:  Clin Infect Dis       Date:  2010-09-01       Impact factor: 9.079

3.  Burden of disease and risk factors for death among children treated for tuberculosis in Malawi.

Authors:  R J Flick; M H Kim; K Simon; A Munthali; M C Hosseinipour; N E Rosenberg; P N Kazembe; J Mpunga; S Ahmed
Journal:  Int J Tuberc Lung Dis       Date:  2016-08       Impact factor: 2.373

4.  Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar.

Authors:  A M Thi; H D Shewade; N T T Kyaw; M M Oo; T K Aung; S T Aung; H N Oo; T Win; A D Harries
Journal:  Public Health Action       Date:  2016-06-21

5.  Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.

Authors:  François-Xavier Blanc; Thim Sok; Didier Laureillard; Laurence Borand; Claire Rekacewicz; Eric Nerrienet; Yoann Madec; Olivier Marcy; Sarin Chan; Narom Prak; Chindamony Kim; Khemarin Kim Lak; Chanroeurn Hak; Bunnet Dim; Chhun Im Sin; Sath Sun; Bertrand Guillard; Borann Sar; Sirenda Vong; Marcelo Fernandez; Lawrence Fox; Jean-François Delfraissy; Anne E Goldfeld
Journal:  N Engl J Med       Date:  2011-10-20       Impact factor: 91.245

6.  Collaborative activities and treatment outcomes in patients with HIV-associated tuberculosis in Viet Nam.

Authors:  T T T Huyen; N V Nhung; H D Shewade; N B Hoa; A D Harries
Journal:  Public Health Action       Date:  2016-03-21

7.  Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy.

Authors:  Stephen D Lawn; Katharina Kranzer; David J Edwards; Matthew McNally; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2010-06-01       Impact factor: 4.177

8.  Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.

Authors:  Mina C Hosseinipour; Gregory P Bisson; Sachiko Miyahara; Xin Sun; Agnes Moses; Cynthia Riviere; Fredrick K Kirui; Sharlaa Badal-Faesen; David Lagat; Mulinda Nyirenda; Kogieleum Naidoo; James Hakim; Peter Mugyenyi; German Henostroza; Paul D Leger; Javier R Lama; Lerato Mohapi; Jorge Alave; Vidya Mave; Valdilea G Veloso; Sandy Pillay; Nagalingeswaran Kumarasamy; Jing Bao; Evelyn Hogg; Lynne Jones; Andrew Zolopa; Johnstone Kumwenda; Amita Gupta
Journal:  Lancet       Date:  2016-03-19       Impact factor: 79.321

9.  Reducing the burden of tuberculosis presenting during the initial months of antiretroviral therapy in resource-limited settings.

Authors:  Stephen D Lawn; David J Edwards; Robin Wood
Journal:  Clin Infect Dis       Date:  2010-01-01       Impact factor: 9.079

Review 10.  HIV and co-infections.

Authors:  Christina C Chang; Megan Crane; Jingling Zhou; Michael Mina; Jeffrey J Post; Barbara A Cameron; Andrew R Lloyd; Anthony Jaworowski; Martyn A French; Sharon R Lewin
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.